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199 Pulmonary function and clinical aspects in cystic ﬁbrosis (CF)
patients chronically colonized with Pseudomonas aeruginosa
S. Lubovich1, S. Zaragoza1, V. Rodriguez1, L. Galanternik1, T. Kohler1, A. Teper1,
P. Ratto1. 1Ricardo Gutierrez Children’s Hospital, Respiratory Center, Buenos
Aires, Argentina
Chronic colonization with Pseudomonas aeruginosa (PA) in CF patients shows
more rapidly decline in pulmonary function (PF).
Objective: To compare the PF and clinical characteristics of CF patients according
to the colonization with PA.
Methods: Observational cross-sectional study. We collected data from CF patients
who were performed at least four sputum cultures from September 2009 to
September 2010. We divided them into four groups according to Leeds Criteria:
Chronic infection, Intermittent colonization, Free and Never. We considered: age,
genetics, pulmonary function, nutritional status, intravenous (IV) antibiotics and PA
antibodies.
Results: We evaluated 97 CF patients: 26% Chronic, 25% Intermittent, 27% Free
and 19 % Never. The current age (median and interquartile range) was 10.7 (8.5
to 16.2), 5.8 (2.78 to 7.67), 5.5 (4.7 to 8.9) and 4.2 (0.97 to 5.3), respectively
(p< 0.001). The homozygous p.508 del was present in 34%, 56%, 29%, and 31%
of patients, respectively (p =NS). PA antibodies was 7.6 (4.5 to 16.5), 1.6 (1 to
1.8), 1.5 (1to 2.6) and 0.8 (0.6 to 1), respectively (p< 0.001). The Zscore BMI was
−0.39 (−1.14 to 0.13), −0.1 (−0.81 to 0.31), 0.19 (−0.28 to 0.83) and 0.11 (−0.94
to 0.37) in each group (p =NS). The FEV1 was 63 (47.5 to 92.2), 79 (54.7 to 108),
99 (85 to 105) and 109 (105.7 to 112), respectively (p = 0.06). (Chronic vs. Free
p = 0.007 and Chronic vs. Never p< 0.001). Iv Antibiotic treatments were required
in 1 (0−1), 1 (1−2), 0 (0−1) and 0 (0−0), respectively (p< 0.01).
Conclusion: Chronic infection with PA determined lower pulmonary function, more
iv antibiotics treatments and had higher level of antibodies than the others groups.
200 Evolution of lung function in cystic ﬁbrosis patients treated for
respiratory tract exacerbation assessed by spirometry and forced
oscillation technique
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The objective of the research was to assess the ability of the forced oscillation
technique (FOT) to detect changes in lung function in patients with cystic ﬁbrosis
(CF) treated with intravenous antibiotics for an acute respiratory tract exacerbation
(RTE).
Methods: Twenty-six CF patients had a lung function evaluation with both spirom-
etry and FOT before and after their treatment course for RTE. The evolution of
both spirometic (FEV1, FVC, MEF25−75) and FOT parameters (5, 10, 15, 20 and
25Hz resistance and reactance: R5 to R25, X5 to X25, resonant frequency: Fres)
was calculated and tested for statistical signiﬁcance with the nonparametric rank
signed test. The correlation between spirometic and FOT parameters was calculated
with the nonparametric Spearman rank test.
Results: The mean age of the 26 patients (53.9% males) was 12.0±3.7 years.
The mean % predicted of FEV1, FVC and MEF25−75 respectively increased of
+15±12%; +12±16%; +17±19% (all p< 0.0001). However, only R5 and R10
absolute values signiﬁcantly had decreased, while the alteration of the other FOT
absolute values was not statistically signiﬁcant. At the beginning of RTE, FEV1
correlated with X5 (r = 0.55, p = 0.0035) and X10 (r = 0.35, p = 0.07) but none of
the other FOT parameters. A weak correlation was found between MEF25−75 and
X5 (r = 0.47, p = 0.014). At the end, none of the spirometric parameters correlated
with any of the FOT parameters.
Conclusion: In contrast to the previous study (Ren et al, 2006), we did not ﬁnd
that FOT was able to detect signiﬁcant changes in lung function in CF treated for
RTE. We conclude that FOT is not a valuable tool for lung function assessment
during CF lung disease.
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Rationale: Trapped air (TA) on expiratory CT scans (TACT) reﬂects small airway
disease, and plays an important role in the pathophysiology of early CF lung disease.
Little is known about the dynamics of TACT over time.
Aims: To assess the course and reversibility of TACT over 2 years.
Methods: TA was assessed on 2 consecutive routine expiratory CT scans (TACT1,
TACT2). Lung tissue was segmented to determine Total Lung Volume (TLV). TA
volume was determined using thresholds between −975 HU and −700 HU (manually
determined). TACT was expressed in percentage TLV. To assess TACT reversibility,
CT2 and its corresponding TA masks were non-rigidly deformed to match CT1.
The volume of TA that was unchanged, disappeared or new relative to CT1 was
measured and expressed in percentage overlap volume. Statistical analysis included
Wilcoxon’s signed rank test.
Results: 26 patients (14 boys) were included. Baseline median (range) age and
FEV1 were 11.9 (5−17) years, and 91 (39–130) %-predicted. Median (range) TACT1
and TACT2 were respectively 9.5% (2−33%) and 8.0% (0−26%) (p = 0.56). Median
(range) TACT volume unchanged, disappeared, and new in CT2 relative to CT1 was
respectively 3.0% (0−12%), 5.3% (1−22%) and 6.6% (0−20%). The proportion new
and reversed TA was signiﬁcantly higher than the proportion stable TA (p = 0.001
and p = 0.003).
Conclusions: In this study, TACT was not progressive over 2 years, and overall,
TA appeared to be more dynamic than static over time.
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Background: Since physical activity and exercise testing became more important
in CF-care the potential risk of exercise testing should be known. The aim of this
study was to identify potential risks of exercise testing in daily clinical routine.
Methods: In a prospektive study in our CF-centre all patients from 6 to 18 years
carried out an incremental exercise test (Ergoline cycle ergometer, Godfrey proto-
col). Oxygen saturation (SpO2), blood pressure (BP), heart rate (HR), ECG data
(PQ interval, QRS duration, cardiac arrhythmia), serum glucose, lactate and clinical
parameters (FEV1%, BMI Z-Score) were measured.
Results: We analyzed data (MW±SD) from 131 patients (61 female, 70 male),
aged 11.7±3.3 years. They were in stable clinical status: FEV1 90±19%, BMI
Z-score −0.5±1; with rest parameters: BP 104±14/72±11mmHg, HR 91±14
beats/minute, SpO2 99±1%. No test had to be stopped because of any abort cri-
terion. Physical capacity (94±20% of norm), maximal HR (181±12 beats/minute)
and lactate (8.1±2.2mmol/l) argue for maximal effort. Under peak exercise we
measured regular values for serum glucose (5.88±3.08mmol/l; min 3.76mmol/l),
BP (153±29/72±15mmHg) and SpO2 (96±2%, min 88%). There was no correla-
tion between minimal SpO2 and absolute SpO2 decline with FEV1, BMI z-score
and/or basic value of SpO2. No patient showed abnormalities of PR interval, QRS
duration and morphology or signiﬁcant cardiac arrhythmia during rest, exercise or
recovery period.
Conclusions: Routinely exercise testing is safe for children with CF in stable clin-
ical conditions. Nevertheless we would recommend a regular incremental exercise
test to exclude possible individual risks for exercise at home.
